首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device.
【24h】

Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device.

机译:使用SilverHawk装置对pop下动脉进行定向旋切术后的两年结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To report the 12- and 24-month results after directional atherectomy (DA) of below-the-knee (BTK) arterial lesions with the SilverHawk device. METHODS: Forty-nine BTK lesions in 36 patients (58% men; mean age 70+/-11 years) with peripheral occlusive disease of the lower limbs were treated with DA; 19 (53%) of the limbs were classified with Rutherford-Becker 4 or 5 ischemia. Target lesions were in the popliteal artery (n = 6, 12%), tibioperoneal trunk (n = 25, 51%), peroneal artery (n = 10, 20%), anterior tibial artery (n = 5, 10%), and posterior tibial artery (n = 3, 6%). Nine (18%) lesions were located in a stent. Twelve lesions extended to 2 artery segments. The average degree of diameter stenosis was 89%+/-10% (range 70%-100%); there were 11 (22%) occlusions. The mean lesion length was 48+/-28 mm. RESULTS: Sixteen (33%) lesions were treated after predilation; 33 (67%) lesions were treated with primary DA. All but 1 (2%) lesion could be treated with DA. In 19 (39%) lesions, additional balloon angioplasty was performed, and 2 (4%) lesions required stent implantation as a result of dissection. The mean stenosis diameter after DA was 12%+/-18% (range 0%-100%). After additional therapy, the mean stenosis diameter was 8%+/-9% (range 0%-100%). A residual stenosis
机译:目的:报告使用SilverHawk装置对膝下(BTK)动脉病变进行定向斑块切除术(DA)后的12个月和24个月结果。方法:对36例下肢周围闭塞性疾病的患者(男58%,平均年龄70 +/- 11岁)中的49例BTK病灶进行DA治疗。 19例(53%)肢体被分类为Rutherford-Becker 4或5缺血。目标病变位于in动脉(n = 6、12%),胫腓骨干(n = 25、51%),腓动脉(n = 10、20%),胫骨前动脉(n = 5、10%),胫后动脉(n = 3,6%)。支架中有9个(18%)病变。十二个病变扩展到2个动脉段。直径狭窄的平均程度为89%+ /-10%(范围70%-100%);有11个(22%)咬合。平均病变长度为48 +/- 28mm。结果:消融后治疗了16个(33%)病变;原发性DA治疗了33个(67%)病变。除1(2%)病变外,所有病变均可用DA治疗。在解剖中,有19个(39%)病变进行了额外的球囊血管成形术,而2个(4%)病变需要支架植入。 DA后的平均狭窄直径为12%+ /-18%(范围0%-100%)。经过额外的治疗后,平均狭窄直径为8%+ /-9%(范围为0%-100%)。在48个(98%)病变中,残余狭窄达到或小于30%。出院前平均踝臂指数从0.48 +/- 0.26显着增加到0.81 +/- 0.32(p <0.05),并在随访期间保持改善。一年后的初次和二次通畅率分别为67%和91%,24个月后分别为60%和80%。通过Kaplan-Meier分析得出的12个月和24个月累积无事件生存率(主要通畅)为58%+ /-8%和46%+ /-9%;在相同的时间间隔,累积生存率(二次通畅)分别为88%+ /-6%和73%+ /-9%。结论:DA可以成功,安全地治疗BTK病变。中期临床结果令人鼓舞。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号